Voice of Pancreatic Cancer Podcast - Targeting the KRAS mutation for more effective cancer treatment with The Froedtert & the Medical College of Wisconsin's Susan Tsai, MD, MHS, FACS and Mandana Kamgar, MD, MPH.
KRAS mutations are present in approximately 25% of tumors, making them one of the most common gene mutations linked to cancer. KRAS drives 32% of lung cancers, 40% of colorectal cancers, and 85% to 90% of pancreatic cancer cases. In this episode, we dive deeper into recent breakthroughs in developing targeted therapies with promising results.
www.froedtert.com/doctors/sus...
www.froedtert.com/doctors/man...